Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials.

× No keyword cloud information.

13 in total

1. Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.

Authors: N L Carlsen; K Ornvold; I J Christensen; H Laursen; J K Larsen
Journal: Virchows Arch A Pathol Anat Histopathol Date: 1992

2. Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.

Authors: Suzanne E Dahlberg; Alan B Sandler; Julie R Brahmer; Joan H Schiller; David H Johnson
Journal: J Clin Oncol Date: 2010-01-19 Impact factor: 44.544

3. Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.

Authors: J L Finlay; J R Geyer; P A Turski; A J Yates; J M Boyett; J C Allen; R J Packer
Journal: J Neurooncol Date: 1994 Impact factor: 4.130

4. Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93.

Authors: Olivia Pagani; Shari Gelber; Marco Colleoni; Karen N Price; Edda Simoncini
Journal: Breast Cancer Res Treat Date: 2013-11-07 Impact factor: 4.872

5. Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery.

Authors: Elfriede Bollschweiler
Journal: Langenbecks Arch Surg Date: 2003-08-14 Impact factor: 3.445

6. The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.

Authors: M Colleoni; Z Sun; G Martinelli; R L Basser; A S Coates; R D Gelber; M D Green; F Peccatori; S Cinieri; S Aebi; G Viale; K N Price; A Goldhirsch
Journal: Ann Oncol Date: 2009-05-25 Impact factor: 32.976

7. Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?

Authors: P Ivanyi; J Koenig; A Trummer; J F Busch; C Seidel; C W Reuter; A Ganser; V Grünwald
Journal: World J Urol Date: 2015-11-19 Impact factor: 4.226

8. Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy.

Authors: Y Nomura; H Tashiro; A Osaki
Journal: Breast Cancer Res Treat Date: 1995 Impact factor: 4.872

9. Hormone replacement therapy and survival after surgery for ovarian cancer.

Authors: R A Eeles; S Tan; E Wiltshaw; I Fryatt; R P A'Hern; J H Shepherd; C L Harmer; P R Blake; C E Chilvers
Journal: BMJ Date: 1991-02-02

10. Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

Authors: H J Wanebo; J Lee; B A Burtness; J A Ridge; M Ghebremichael; S A Spencer; D Psyrri; E Pectasides; D Rimm; F R Rosen; M R Hancock; K A Tolba; A A Forastiere
Journal: Ann Oncol Date: 2014-07-09 Impact factor: 32.976